|
|
Vaccine Detail
|
ASFV-G-∆I177L |
| Vaccine Information |
- Vaccine Name: ASFV-G-∆I177L
- Target Pathogen: African Swine Fever Virus
- Target Disease: African Swine Fever
- Type: Live, attenuated vaccine
- Status: Research
- Host Species for Licensed Use: None
- Antigen: The virus antigen was produced from Vero cells infected with a Vero-adapted ASFV strain.(Borca et al., 2021)
- I177L Gene
gene engineering:
- Type: Deletion
- Description: Deletion of the I177L gene from the genome of the highly virulent ASFV strain Georgia(Borca et al., 2021)
- Detailed Gene Information: Click Here.
- Immunization Route: oronasally or intramuscularly
- Description: ASFV-G-∆I177L Is alive attenuated vaccine candidate developed by deleting the I177L gene from the genome of the highly virulent pandemic ASFV strain Georgia. (Borca et al., 2021)
|
| Host Response |
|
|
| References |
|
|
|
